BENJAMIN R. YERXA - 02 Mar 2022 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
CLSD
Transactions as of
02 Mar 2022
Transactions value $
$0
Form type
4
Filing time
04 Mar 2022, 16:09:55 UTC
Next filing
24 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Stock Option (right to buy) Award $0 +30K $0.00 30K 02 Mar 2022 Common Stock 30K $1.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option will vest and become exercisable in 36 equal monthly installments beginning on April 2, 2022, subject to the Reporting Person's continuous service as of such vesting dates.